An important aspect of peripheral T cell development is the differentiation from naive into memory cells. To distinguish naive from memory cells, CD45RA and CD11a are commonly used: CD45RA ⍣ or CD11a dim T cells are regarded as naive, while CD45RA -or CD11a bright T cells are thought to be of memory type. There is, however, a CD8 ⍣ T cell subset which is CD45RA ⍣ and at the same time CD11a bright . It increases with age and in patients with systemic viral infections, though its functional role in the immune response is unknown. In the present study, we give evidence that this subset is related to memory-like T cells as it produces IFN-γ and tumor necrosis factor-α, contains high levels of perforin, and expresses CD95 in the same way as memory-type CD45RA -/ CD11a bright CD8 ⍣ T cells. Since it contains a high percentage of CD28 -and CD57 ⍣ cells, is increased in size and granularity, and is transiently expressed following in vitro stimulation of naive CD8 ⍣ T cells, we speculate that this subset mainly represents recently activated effector T cells that are able to interact with CD80 and CD86 (B7-1 and B7-2 respectively) negative tissue cells.
Introduction
Following appropriate antigen presentation naive T cells proliferate and differentiate into primary effector T cells. Recirculating T cells which have undergone activation in the past show a homing pattern distinct from that of naive T cells. The up-regulation of several adhesion molecules allows those cells to infiltrate into non-immune tissues and to mediate a local immune response. In order to limit clonal expansion and to prevent overwhelming T cell response (which may result in tissue destruction and autoimmunity), effector T cells are highly susceptible to activation-induced apoptosis following repeated cross-linking of their T cell receptors (1) .
A significant proportion of antigen-triggered naive T cells develop into memory-type T cells. Memory-type T cells can be triggered to become secondary effector T cells following second antigen exposure. Activated primary and secondary T effector cells may express IL-2, IFN-γ, tumor necrosis factor (TNF)-α, IL-3, IL-4, IL-5, etc. (2) .
The wish to identify T cell surface markers which would reliably distinguish memory cells from naive cells has marked many research projects in recent years. It has become common practice to use CD45RA (or CD45RO) in order to make this distinction, but CD11a has also been used.
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Transmitting editor: A. Radbruch Received 9 April 1998, accepted 26 August 1998 Expression of CD45RA (CD45RA ϩ ) and low level expression of CD11a (CD11a dim ) have been thought to characterize naive cells. No CD45RA (CD45RA -) expression, or expression of high levels of CD11a (CD11a bright ), has generally been associated with memory (3) . However, it is difficult to discriminate primary and secondary effector T cells, and resting memory-type T cells, on the basis of CD45RA/CD45RO/ CD11a expression. Interestingly, in CD8 ϩ T cells, three subsets exist with respect to CD45RA and CD11a expression. Two subsets have either naive or memory characteristics (CD45RA ϩ /CD11a dim or CD45RA -/CD11a bright respectively) while the third one seems to have naive and memory type features at the same time, and may be considered to represent an intermediate type (CD45RA ϩ and CD11a bright ) (4, 5) . This intermediate type subset was found to increase with age (6) , and in patients infected with HIV (7) and other systemic viral infections (our own unpublished observations). This suggested a relationship between immune activation and appearance of CD45RA ϩ / CD11a bright CD8 ϩ T cells in the periphery, although the function of these cells was still unknown.
To characterize these cells from a functional point of view we compared their expression of cytokines, perforin, CD95, CD57, as well as their size and granularity with that of their naive CD45RA ϩ /CD11a dim and memory-like CD45RA -/ CD11a bright counterparts. Also, we looked at their need for co-stimulation, evaluated by comparing CD28 expression. We furthermore analyzed the fate of these cells following in vitro stimulation. Based on these results and analysis of the literature, we speculate that this phenotype represents non-proliferating, recently activated effector T cells.
Methods

Cell preparation and in vitro stimulation
Human peripheral blood mononuclear cells (PBMC) from adult healthy donors and cord blood were isolated by Ficoll-Paque (Pharmacia, Freiburg, Germany) density gradient centrifugation (PBMC from cord blood contained 15-20% granulocytes). Cells were cultured in RPMI 1640 (Biochrom, Berlin, Germany) supplemented with 10% (v/v) FCS (Biochrom) and 2 mM glutamine (Biochrom). Anti-CD3 mAb stimulation was done in Falcon six-well plates (Becton Dickinson, Heidelberg, Germany) with 10 6 cells/ml (3 ml/well). Cells were stimulated with the solidphase immobilized anti-CD3 mAb OKT3/Orthoclone (10 ng/ well) (Cilag, Munich, Germany) and rIL-2 (30 U/ml) (HoffmannLaRoche, Basel, Switzerland) for various periods of time before flow cytometry analysis of cell surface marker expression and measurement of apoptosis. For stimulation with phorbol myristate acetate (PMA) and ionomycin we used a commercially available stimulation kit as suggested by the supplier (Hö lzel Diagnostika, Cologna, Germany). Briefly, PBMC were stimulated in 1.5 ml test tubes (Eppendorf-Netheler-Hinz, Hamburg, Germany) at 10 6 cells/ml (1 ml/test tube) with PMA and ionomycin for 6 h. Monensin was added to prevent cytokine secretion. For mixed lymphocyte culture PBMC (2ϫ10 6 cells/ml, 100 µl/well) from cord blood were stimulated with irradiated (90 Gy) IM-9 cells (2ϫ10 5 CD11a-phycoerythrin (PE), CD45RA-FITC/PE, CD95-FITC (clone UB2), CD57-FITC and CD28-FITC were purchased from Coulter-Immunotech (Hamburg, Germany), CD11a-biotin was from Serva (Heidelberg, Germany), streptavidin-PerCP and CD8-PerCP were from Becton Dickinson. Anti-IFN-γ-FITC and anti-TNF-α-FITC were from Hö lzel Diagnostika, and anti-perforin-PE from Alexis Deutschland (Grü nberg, Germany). Anti-IL-4-PE and anti-IL-5-PE were purchased from PharMingen (Hamburg, Germany). As negative controls we used IgG1-FITC/PE from Coulter-Immunotech and IgG2b-PE from Alexis.
Three-color FCM analysis
For FCM, PBMC or immunomagnetically purified CD8 ϩ T cells separated as described above were incubated with saturating amounts of mAb for 20 min at 4°C in the dark. Then, cells were washed and analyzed on a FACScan (Becton Dickinson) using three-color FCM and Lysys II software (Becton Dickinson). For biotin-labeled antibodies additional incubation with streptavidin-PerCP was done before analysis. Living lymphocytes were gated in a forward/side scatter dot-plot as well as activated lymphoblasts. To exclude NK cells only CD8 bright lymphocytes were selected (4). For evaluation of unspecific binding, staining with irrelevant IgG was performed.
For analysis of intracellular cytokine and perforin expression, CD8 ϩ T cells were separated from in vitro stimulated and unstimulated PBMC as described above. Then cells were fixed by paraformaldehyde and permeabilized by saponin followed by incubation with saturing amounts of mAb (anti-IFN-γ-FITC, anti-TNF-α-FITC, anti-IL-4-PE, anti-IL-5-PE, or anti-perforin-PE, CD45RA-PE/-FITC, CD11a-biotin-streptavidin-PerCP) and FCM analysis.
Separation of CD8 ϩ cells
For separating CD8 ϩ cells PBMC were labeled with anti-CD8 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and magnetically separated by MACS (Miltenyi Biotec). Samples of the separated cells were analyzed to confirm their appropriate phenotype. More than 93% of the separated cells were CD8 ϩ CD3 ϩ CD16 -, Ͻ3% were CD8 ϩ CD3 -CD16 ϩ (NK cells) and Ͻ4% were CD8 -/CD3 ϩ /CD16 -or debris.
Statistical analysis
Statistical analysis was done with Wilcoxon matched-pairs signed-ranks test using SPSS software. Data are shown as mean Ϯ SEM. 
Results
Definition of the CD8 ϩ T cell subsets
Regarding CD45RA expression, T cells can be divided into CD45RA bright , CD45RA dim and CD45RA -cells. Our studies focussed on the CD45RA bright /CD11a bright CD8 ϩ T cell subset. Therefore, when gating CD45RA ϩ cells we only looked on CD45RA bright cells, and included both CD45RA dim and CD45RA -cells in the CD45RA -subset (Fig. 1A) CD45RA bright /CD11a bright CD8 ϩ T cells express CD95, are heterogenous in their expression pattern of CD28 and CD57 and are both increased in size and granularity As CD95 (Fas/APO-1) expression on T cells is a marker for previous antigen contact in vivo (9) , we analyzed CD95 expression on isolated CD8 ϩ T cell subsets from healthy adult donors. While all CD11a dim CD8 ϩ T cells were found to be CD95 -, the great majority of CD11a bright CD8 ϩ cells were CD95 ϩ , irrespectively from their CD45RA expression. Representative results obtained from one donor are shown in Fig. 2 .
In agreement with previously published data (5), lack of CD28 expression defined a distinct subset of CD11a bright CD8 ϩ T cells. Analyzing the distribution of CD28 -cells within CD45RA bright and CD45RA -cells we found a significantly higher proportion of CD28 -cells within the CD45RA bright / CD11a bright than in the CD45RA -/CD11a bright subset (67.2 Ϯ 5.99 and 30.1 Ϯ 4.68% respectively, P Ͻ 0.05) (Fig. 3A) . Figure 4 (A) demonstrates the results obtained from one donor as a representative. Interestingly, most of the CD28 -cells within the CD45RA -subset showed a CD45RA dim phenotype (Fig. 4A) .
The expression of CD57 on CD8 ϩ T cell subsets is shown in Fig. 3(B) . The highest percentage of CD57 ϩ cells was found within the CD45RA bright /CD11a bright CD8 ϩ T cell subset followed by CD45RA -/CD11a bright CD8 ϩ T cells (42.6 Ϯ 13.38 and 21.4 Ϯ 7.68% respectively, P Ͻ 0.05). Figure 4 demonstrates the results obtained from one donor as a representative. As for CD28 expression, the main proportion of CD57 ϩ cells within the CD45RA -compartment was found to be CD45RA dim (Fig. 4B) .
Comparing size and granularity of all three CD8 ϩ T cell subsets by using forward and sideward scatter parameters obtained by FACS analysis, both CD11a bright subsets were shown to be significantly increased in size and granularity compared to CD45RA ϩ /CD11a dim cells. CD45RA bright / CD11a bright CD8 ϩ T cells, however, were shown to be even more increased in size and granularity than CD45RA -/ CD11a bright cells (Fig. 5) .
Taken together, these data show that CD45RA bright / Size and granularity were measured by FACS using the parameters forward scatter (as parameter for size) and side scatter (as parameter for granularity). The values obtained for the CD45RA bright /CD11a dim subset were taken as 100%. The values obtained for the other both subsets are shown in percent in relation to the CD45RA bright /CD11a dim subset. For every subset the mean Ϯ SEM of five independent experiments is shown. ϩ P Ͻ 0.05 versus CD45RA bright /CD11a dim subset, # P Ͻ 0.05 versus CD45RA -/CD11a bright , Wilcoxon test. CD11a bright 86.9 Ϯ 1.31 and 66.7 Ϯ 5.11% respectively). In contrast, only a small proportion of the CD45RA bright /CD11a dim cells showed production capacity (9.5 Ϯ 1.08 and 8.2 Ϯ 2.09% respectively) (Fig. 6B) . None of the three CD8 ϩ T cell subpopulations showed detectable levels of IL-4 or IL-5 (data not shown). Controls, which had been cultured in medium alone, showed Ͻ2% of cytokine-producing cells (not shown). Figure 7 (B and C) shows the results obtained from one donor as a representative.
Thus, besides phenotypical similarities between CD45-RA bright /CD11a bright CD8 ϩ T cells and their memory-like CD45RA -/CD11a bright counterparts, they also show striking functional similarities which confirms the idea of CD45RA bright / CD11a bright CD8 ϩ T cells to be in vivo activated cells as they show cytotoxic potential and cytokine production capacity.
CD45RA bright /CD11a bright CD8 ϩ T cells develop from naive cells following in vitro stimulation
Regarding their CD45RA and CD11a expression, CD45-RA bright /CD11a bright CD8 ϩ T cells seem to represent an intermediate state between CD45RA bright /CD11a dim and CD45RA -/ CD11a bright CD8 ϩ T cells. As human cord blood contains almost only naive CD45RA bright /CD11a dim cells we stimulated PBMC from cord blood with OKT3/rIL-2 as well as in mixed lymphocyte culture using IM-9 cells as antigen-presenting cells to analyze appearance of the CD45RA bright /CD11a bright subset following in vitro stimulation. PBMC cultured in medium only were used as control (Fig. 8A) . In both in vitro stimulation models, polyclonal stimulation (Fig. 8B) as well as oligoclonal, antigen-specific stimulation (Fig. 8C, D and E) , the appearance of CD45RA bright /CD11a bright cells was only of transient nature. As almost all CD8 ϩ T cells showed a CD45RA -/ CD11a bright phenotype 96 h following in vitro stimulation we suspect that the disappearance of CD45RA bright /CD11a bright cells was either due to switching to the CD45RA -/CD11a bright phenotype, as implicated by counter plot analysis (Fig. 9) , or dying following activation, or even both. 
Discussion
Our results indicated that CD45RA bright /CD11a bright CD8 ϩ T cells are more closely related to the memory-type CD45RA -/ CD11a bright CD8 ϩ T cell subset than to the naive-type CD45RA bright /CD11a dim subset. This was true for phenotypic as well as functional parameters. So, they expressed CD95, were increased in size and granularity, and expressed high levels of perforin and cytokines. Thus, regarding the CD8 ϩ T cell subset, CD45RA is not useful in discriminating naive and memory cells.
Despite these obvious similarities with CD45RA -/CD11a bright CD8 ϩ T cells, CD45RA bright /CD11a bright CD8 ϩ T cells differed from the former in other aspects: CD45RA bright /CD11a bright cells were shown to be even more increased in size and granularity, contained higher proportions of CD28 -and CD57 ϩ cells, and expressed more perforin compared with CD45RA -/ CD11a bright cells.
Furthermore, when stimulating human cord blood-derived PBMC in vitro, we found that the CD45RA bright /CD11a bright CD8 ϩ T cell phenotype exists only transiently. Based on the above described results and analysis of the literature we came to the following conclusions: CD45RA bright / CD11a bright CD8 ϩ T cells may develop from naive CD45-RA bright /CD11a dim CD8 ϩ T cells following activation. Besides up-regulation of CD11a they also have increased CD95 expression. The expression of high levels of CD11a enables peripheral blood T cells to infiltrate tissues via endothelial ICAMs (11) and to interact with ICAMs on target cells (12) . Activation-induced apoptosis via TCR-CD3 complex can be blocked by inhibiting CD95-CD95 ligand interactions, at least in T cell hybridomas and Jurkat cells. This indicated CD95 ϩ cells to be more susceptible to activation-induced apoptosis than CD95 -cells (13) (14) (15) (16) . However, the functional role of upregulated CD95 expression remained obscure at least in our system as activation-induced apoptosis was not blocked by a neutralizing anti-CD95 mAb (data not shown). Lynch et al. speculated about a co-stimulatory role for CD95 (17) . That could explain the fact that CD95 was one of the first activation makers which appeared following in vitro stimulation (data not shown). Regarding CD28 and CD57 expression, CD45-RA bright /CD11a bright cells do not represent a homogenous cell population. CD28 is supposed to be of major importance as a co-stimulatory molecule (18) . However, it is not necessarily expressed on all activated T cells. Interestingly, CD28 -T cells are functionally active (measured by their cytotoxic capacity) but unable to proliferate following in vitro stimulation (19) . CD28 -T cells were found to lack gene expression for the p55 α chain of the IL-2 receptor (20) . It may be concluded, therefore, that CD28 -/CD11a bright CD8 ϩ T cells are of a nonproliferating end-stage differentiated effector type (20) . This idea is supported by the recent observation that in a given individual, CD28 -T cells have shorter telomers than CD28 ϩ T cells, suggesting that they have passed through a greater number of cell cycles (21) . Loss of CD28 expression may increase susceptibility to activation-induced apoptosis (22) , probably as the consequence of a lack of up-regulation of members of the bcl family (23) . Thus, repeated stimulation of CD28 -cells could lead to functional inactivation and cell death. This may explain the only transient appearance of the CD45RA bright /CD11a bright CD8 ϩ T cell subset following stimulation (see Figs 8 and 9) . In contradiction to the latter stands the fact that we were not able to induce naive CD8 ϩ T cells to become CD28 -with OKT3/rIL-2 or allogenic stimulation. The function of CD57 on CD8 ϩ T cells is not completely understood. Evidence exists that they represent suppressor T cells (24, 25) . However, Kern et al. demonstrated the biggest part of the CD57 ϩ CD8 ϩ T cell subset to be CD28 -(but not all CD28 -cells are CD57 ϩ ) (20) and therefore to be of a non-proliferating end-stage differentiated effector type as it was concluded for CD28 -T cells (20) . The perforin content in all CD11a bright CD8 ϩ T cells underlines the hypothesis of CD57 ϩ CD8 ϩ T cells to be effector T cells (CD57 ϩ cells are always CD11a bright ) or at least to have cytotoxic capacity. Interestingly, another group showed that CD57 ϩ CD8 ϩ T cells seem to be activated but do not represent antigen-specific T cells (26) . Taken together with the observation that NK cells (determined as lymphocytes with high CD16 expression) show a CD45RA bright /CD11a bright phenotype (data not shown), CD45RA bright /CD11a bright CD8 ϩ T cells may represent non-MHC-restricted effector T cells. In conclusion, CD45RA bright /CD11a bright CD8 ϩ T cells seem to represent a transient state of activated T cells. Disappearance of CD28 and IL-2R but up-regulation of adhesion and effector molecules makes most of them candidates for non-proliferating end-stage differentiated effector T cells undergoing activation-induced apoptosis following repeated stimulation, whereas a minor part of them may switch to the CD45RA -/CD11a bright subset. 
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